MYBL2 mRNA expression as a potential biomarker of therapeutic response to genotoxic treatments in myelodysplastic syndrome. (2018)
Attributed to:
The role of MYBL2 in the age-related development of blood disorders
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.18632/oncotarget.26477
PubMed Identifier: 30680058
Publication URI: http://europepmc.org/abstract/MED/30680058
Type: Journal Article/Review
Volume: 9
Parent Publication: Oncotarget
Issue: 101
ISSN: 1949-2553